Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Massachusetts General Hospital Cancer Center
W

52 y/o Female With Localized PDAC: How Adequate Is Current Approach? Why Is Staging Important?

By Massachusetts General Hospital Cancer Center FEATURING Wells Messersmith, Theodore Hong
By Massachusetts General Hospital Cancer Center FEATURING Wells Messersmith, Theodore Hong
165 views
May 26, 2021
Comments 1
Login to view comments. Click here to Login
Grand Rounds
53:56

Oncologic Anthropology: Genetics of High-Risk/TNBC and African Ances…

Massachusetts General Hospital Cancer Center

L. Newman

11 views
56:23

Environmental Influences on Colorectal Cancer

Massachusetts General Hospital Cancer Center

J. Carethers

19 views
47:34

Confronting Inequity in Modern Therapy for Rare Melanomas

Massachusetts General Hospital Cancer Center

A. Shoushtari

75 views
47:29

Personalizing Care for Older Adults With Cancer

Massachusetts General Hospital Cancer Center

H. Klepin

11 views
50:19

Engineering CAR T-Cells: Combatting Tumor Resistance and Relapse

Massachusetts General Hospital Cancer Center

R. Brentjens

21 views
46:25

Advancing Therapies for Children and Adults With Rare Solid Tumors o…

Massachusetts General Hospital Cancer Center

B. Widemann

7 views
49:26

Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond

Massachusetts General Hospital Cancer Center

M. Konopleva

22 views
12:33

Endocrine Therapy in EBC: Latest Trial Data on Genomic Testing

Massachusetts General Hospital Cancer Center

N. Davidson

35 views
10:26

Radiation Therapy and Localized PDAC: NACRT vs. NAT, Radiation & Imm…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

27 views
18:49

RT & laPAC: Application in Unresectable Disease, Dose Escalation & P…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

16 views
36:51

The Future of Cancer Screening: Non-Standard Screens, Death Rates & …

Massachusetts General Hospital Cancer Center

S. Raoof

25 views
09:54

Augmenting Response to Endocrine Therapy in BC: The Role of Combinat…

Massachusetts General Hospital Cancer Center

N. Davidson

36 views
15:35

ESR1 Mutations and Other Mutational Signatures in HR+/HER2- MBC: Rev…

Massachusetts General Hospital Cancer Center

N. Davidson

425 views
12:39

Key Adjuvant Studies for Resected Pancreatic Adenocarcinoma: What Da…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

193 views
12:09

The Role of CDK4/6i in Endocrine Therapy of HR+/HER2- MBC: 1/2L Trea…

Massachusetts General Hospital Cancer Center

N. Davidson

309 views
31:20

Understanding Responses to Cancer Therapy: Lessons Learned From Tran…

Massachusetts General Hospital Cancer Center

J. Wargo

8 views
12:43

What Is the Role of Diet in Response to Cancer Treatment?

Massachusetts General Hospital Cancer Center

J. Wargo

134 views
36:18

Molecular Profiling of Gliomas: Therapeutic Utility of Prognostic & …

Massachusetts General Hospital Cancer Center

A. Chakravarti

105 views
22:43

The Use of IO in SCLC: Navigating Established IO Mono & Combination …

Massachusetts General Hospital Cancer Center

T. Owonikoko

138 views

Enhancing the Benefit of IO in SCLC: Considering Emerging Predictive…

Massachusetts General Hospital Cancer Center

T. Owonikoko

98 views
15:48

52 y/o Female With Localized PDAC: How Adequate Is Current Approach?…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

165 views
48:13

Late Recurrences in ER+ BC: Does Adjuvant ET Decrease the Risk of Re…

Massachusetts General Hospital Cancer Center

D. Hayes

796 views